These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1966956)

  • 1. Recent advances in psychiatric brain imaging.
    Sedvall G; Farde L; Nybäck H; Pauli S; Persson A; Savic I; Wiesel FA
    Acta Radiol Suppl; 1990; 374():113-5. PubMed ID: 1966956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotransmitter receptor imaging in Alzheimer's disease.
    Sedvall G; Nybäck H; Farde L; Persson A
    J Neural Transm Suppl; 1987; 24():43-8. PubMed ID: 2824693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
    Farde L; Eriksson L; Blomquist G; Halldin C
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):696-708. PubMed ID: 2528555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.
    Lassen NA; Bartenstein PA; Lammertsma AA; Prevett MC; Turton DR; Luthra SK; Osman S; Bloomfield PM; Jones T; Patsalos PN
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):152-65. PubMed ID: 7798333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of radioligands in schizophrenia research.
    Sedvall G; Farde L; Hall H; Halldin C; Karlsson P; Nordström AL; Nyberg S; Pauli S
    Clin Neurosci; 1995; 3(2):112-21. PubMed ID: 7583617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET scanning--a new tool in clinical psychopharmacology.
    Sedvall G; Farde L; Hall H; Pauli S; Persson A; Wiesel FA
    Psychopharmacol Ser; 1988; 5():27-33. PubMed ID: 3045802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.
    Farde L; Halldin C; Stone-Elander S; Sedvall G
    Psychopharmacology (Berl); 1987; 92(3):278-84. PubMed ID: 2957716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in PET scan imaging of neuroreceptors in schizophrenia.
    Sedvall G; Pauli S; Farde L; Karlsson P; Nyberg S; Nordström AL
    Isr J Psychiatry Relat Sci; 1995; 32(1):22-9. PubMed ID: 7622344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography.
    Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M
    Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.
    Farde L
    Psychopharmacology (Berl); 1992; 107(1):23-9. PubMed ID: 1534178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain.
    Hall H; Sedvall G; Magnusson O; Kopp J; Halldin C; Farde L
    Neuropsychopharmacology; 1994 Dec; 11(4):245-56. PubMed ID: 7531978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of neuroreceptors in schizophrenia.
    Sedvall G; Pauli S; Karlsson P; Farde L; Nordström AL; Nyberg S; Halldin C
    Eur Neuropsychopharmacol; 1995; 5 Suppl():25-30. PubMed ID: 8775755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride.
    Hall H; Farde L; Sedvall G
    J Neural Transm; 1988; 73(1):7-21. PubMed ID: 2969950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of [11C]FLB 457 binding to extrastriatal dopamine receptors in the human brain.
    Olsson H; Halldin C; Swahn CG; Farde L
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1164-73. PubMed ID: 10532641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity.
    Fujimura Y; Ito H; Takahashi H; Yasuno F; Ikoma Y; Zhang MR; Nanko S; Suzuki K; Suhara T
    Nucl Med Biol; 2010 Oct; 37(7):831-5. PubMed ID: 20870158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man.
    Farde L; Hall H; Pauli S; Halldin C
    Synapse; 1995 Jul; 20(3):200-8. PubMed ID: 7570351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.
    Laihinen A; Rinne JO; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():151. PubMed ID: 1666759
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.
    Farde L; Pauli S; Hall H; Eriksson L; Halldin C; Högberg T; Nilsson L; Sjögren I; Stone-Elander S
    Psychopharmacology (Berl); 1988; 94(4):471-8. PubMed ID: 3131792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.
    Smith GS; Schloesser R; Brodie JD; Dewey SL; Logan J; Vitkun SA; Simkowitz P; Hurley A; Cooper T; Volkow ND; Cancro R
    Neuropsychopharmacology; 1998 Jan; 18(1):18-25. PubMed ID: 9408915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.